Biotecnología

Biotecnología

UC San Diego Computer Scientist Plays Major Role in $25M Cancer Grand Challenges Project
21/06/2022 - Computer scientist Vineet Bafna is part of a team of world-class researchers that has been awarded a five-year, $25 million grant to learn how the destructive genetic lesion extrachromosomal DNA...
BioCina Opens New GMP Plasmid DNA Manufacturing Suite
21/06/2022 - Equipped with up to 300 L single use fermentation capacity and suitably scaled downstream processing equipment.
Curia and Replicate Bioscience Enter srRNA Collaboration
13/06/2022 - To create groundbreaking development platform for self-replicating RNA.
Avantor and Cytovance Biologics Enter Plasmid DNA Development Collaboration
16/05/2022 - Will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers.
Avantor, Cytovance Biologics Enter Plasmid DNA Development Pact
16/05/2022 - Will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers.
BioCina Awarded Grant to Advance RNA Vaccines and Therapeutics
22/04/2022 - Will collaborate with the University of Adelaide and Cytiva to address emerging challenges.
Computerized, rolling DNA motors move molecular robotics to next level
11/04/2022 - Chemists integrated computer functions into rolling DNA-based motors, opening a new realm of possibilities for miniature, molecular robots. These DNA-based motors combine computational power with the...
Revamped design could take powerful biological computers from the test tube to the cell
11/04/2022 - Researchers may have developed long-lived biological computers that could potentially persist inside cells. Researchers forgo the traditional DNA-based approach, opting instead to use the nucleic...
Live wire: New research on nanoelectronics
11/04/2022 - Researchers show that certain proteins can act as efficient electrical conductors. In fact, these tiny protein wires may have better conductance properties than similar nanowires composed of DNA,...
New, Highly Accurate Algorithm Scales Ability to Assemble Complete Genomes
09/03/2022 - An international team led by computer scientists at UC San Diego has shown that a new genome assembly algorithm can vastly improve large genomes reconstruction, the process by which DNA snippets are...
CureVac Launches Company Designed to Advance The RNA Printer
03/03/2022 - The new entity will be led by Dr. Markus Bergmann.
Touchlight, Versameb Enter Development, Manufacturing Pipeline Pact
03/03/2022 - Enables Versameb to use Touchlight’s proprietary doggybone DNA vector technology to support the development of novel mRNA-based therapeutics.
CureVac Launches Fully-Owned Company Designed to Advance The RNA Printer
02/03/2022 - The new entity will be led by Dr. Markus Bergmann.
Touchlight and Versameb Enter Development & Manufacturing Pipeline Agreement
02/03/2022 - Enables Versameb to use Touchlight’s proprietary doggybone DNA vector technology to support the development of novel mRNA-based therapeutics.
Lilly Launches the Institute for Genetic Medicine
02/03/2022 - New $700 million facility will headquarter research efforts in Boston and New York to accelerate the development of RNA and DNA-based medicines.
Remix Therapeutics, Janssen Enter Small Molecule RNA Alliance
22/02/2022 - Collaboration leverages Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.
Simplifying RNA Editing for Treating Genetic Diseases
11/02/2022 - New research led by bioengineers at the University of California San Diego could make it much simpler to repair disease-causing mutations in RNA without compromising precision or efficiency. The new...
AskBio, Touchlight Restructure Former JV, Touchlight AAV
09/02/2022 - Both parties benefit from co-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA.
Altasciences Names Wendell Davis VP, Pathology
09/02/2022 - Davis brings experience evaluating small molecules, biologics, oligonucleotide, and an array of RNA therapeutics modalities.
Recipharm Acquires Portuguese CDMO to Bolster Biologics Offering
02/02/2022 - GenIbet specializes in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome.
Building Robust Collaborations to ‘ATTACK’ Future Pandemics
20/01/2022 - Six University of California campuses, in coordination with two national labs and more than one dozen industry partners, have formed the University of California-National Labs Antiviral Treatments...